Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

DOI Full Paper Access

207

Citations

25

References

2022

Year

Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon, Nathalie Fiaschi, Edward Kim, Stephen C. Ward, Zhen Zhao, Joel Kim, Paul Kennedy, Ganesh Gunasekaran,

The Lancet. Gastroenterology & hepatology

Surgical OncologyHepatologyResectable Hepatocellular CarcinomaNeoadjuvant CemiplimabMedicineLiver CancerCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaMolecular OncologyRadiologyHealth Sciences

References

	Year	Citations

Page 1

Page 1